Set up in less than 8 month by Jean-Pol Detiffe, founder and ex-CEO of DNAVision, OncoDNA is focused on the analysis of tumors'DNA. Through completed or targetted sequencing, OncoDNA aims to help the medical follow-up and the choice of the most accurate treatment, according to the genomic profile of the patient's tumor. This "personalized medicine" is possible thanks to news performing technologies, developped in the last few years in the field of DNA sequencing.

OncoDNA's shareholding counts on Bio.be, partner-shareholder of the Institut de Pathologie et Génétique (IPG), Sambrinvest and private investors like Jean Stephenne (GSK Biologicals ex-chairman) and François Blondel (ex CEO of IBT and chairman of Compagnie du Bois Sauvage). The company is also supported by Wallonia (SPW - département du développement technologique) in the development of a new product, which will be product very soon by OncoDNA.

Contact: Jean-Pol Detiffe, founder

Avenue George Lemaitre 25
B-6041 Gosselies.
T. +32 (0)